Tirzepatide
Compounded dual GIP/GLP-1 receptor agonist for weight management
- Rx required
- Provider approved
- Ships nationwide
What it is
A compounded dual agonist. It works on two gut-hormone receptors at once, GIP as well as GLP-1, where semaglutide works on one. Both are involved in appetite and in how the body handles blood sugar.
How it helps
- Acts on two incretin receptors at once, which can make weight management more effective
- Tends to blunt appetite more strongly than single-agonist options
- Supports better insulin sensitivity and blood sugar regulation
- Associated with lower visceral fat
- Linked to broader improvements in metabolic markers
Starting from $495 for a minimum of 3 months
Start TreatmentYour intake and prescription are handled by Karpa Health, our licensed pharmacy partner. A physician reviews every request before anything is dispensed, and each treatment is approved on its own.
Prescription therapy. Available only after a medical review by our clinical team, and used under a licensed provider’s supervision. Nothing on this page is medical advice, and it has not been evaluated by the FDA.
Before you start
Starting treatment here means answering the questionnaire, not paying for anything. A provider reads your answers and decides whether this is right for you; if it is, they set the strength and the course. Programs run for a minimum of three months and are billed for that full term. Nothing is charged before a provider has said yes.
See the telehealth consent and the refund policy for the detail.
